The cluster is routine and non-informative, all sales are tied to derivative exercises and vesting, with dollar amounts trivial relative to market cap. No bearish read-through. Monitor for any upcoming earnings or pipeline catalysts that could drive stock movement independent of insider activity.
NBIX drugs
NBIX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 5 $163.88entry
- T+1 · 5mo ago −0.46%α −0.69% · $163.12
- T+5 · 5mo ago −2.51%α −3.08% · $159.76
- T+20 · 4mo ago +6.24%α +4.37% · $174.10
- T+60 · 3mo ago −6.37%α −10.37% · $153.44
Price Chart
How similar events traded
Executive Summary
Four NBIX C-suite insiders sold a total of $4.93M in open-market shares over a 7-day window, with the largest sales by the Chief Human Resources Officer ($2.20M) and Chief Scientific Officer ($1.76M). The cluster is entirely sell-side, with no open-market purchases, and all sales are accompanied by derivative exercises or tax-withholding transactions, suggesting a liquidity/vesting pattern rather than a coordinated bearish signal. At $4.93M, the cluster represents ~0.03% of NBIX's $16.6B market cap, a trivial proportion that does not warrant a bearish read.
Key Financial Metrics
Key Facts
- 4 insiders sold $4.93M in open-market shares over 7 days (May 26–June 2, 2026)
- Largest seller: Chief Human Resources Officer Julie Cooke sold $2.20M on June 2
- Chief Scientific Officer Jude Onyia sold $1.76M on June 1
- All sales are accompanied by derivative exercises or tax-withholding transactions (non-cash events)
- Total cluster value is ~0.03% of NBIX's $16.6B market cap, well below the 0.1% materiality threshold
- No open-market purchases in the cluster; net direction is selling
Financial Impact
Total insider sales of $4.93M, representing ~0.03% of market cap
Risk Factors
- Insider sales are not predictive of near-term stock performance in this context
- No material risk identified from this cluster alone
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NBIX-1780610678145 |
Track record
30 reports on NBIX
3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +27.40% at T+60 after the Apr 6, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $174.41 Now $165.31 −5.22% settles Dec 10
- Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
- Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
- Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
- Nov 2, 202614d ago Press Release Bullish 6/10 No price data
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
- Oct 30, 202617d ago 144 Neutral 1/10 Entry $145.35 Now $165.31 +13.73% settles Dec 1
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $146.10 Now $165.31 +13.15% settles Nov 30
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $145.53 Now $165.31 +13.59% settles Nov 25
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers